Ace J. Hatch

604 total citations
21 papers, 468 citations indexed

About

Ace J. Hatch is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Ace J. Hatch has authored 21 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Ace J. Hatch's work include Colorectal Cancer Treatments and Studies (10 papers), Lung Cancer Treatments and Mutations (7 papers) and Genetic factors in colorectal cancer (6 papers). Ace J. Hatch is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Lung Cancer Treatments and Mutations (7 papers) and Genetic factors in colorectal cancer (6 papers). Ace J. Hatch collaborates with scholars based in United States, United Kingdom and Japan. Ace J. Hatch's co-authors include John D. York, Sumit Prakash, Andreas Matouschek, Tomonao Inobe, Andrew B. Nixon, Herbert I. Hurwitz, Donna Niedzwiecki, Alan P. Venook, Kouros Owzar and Alexander B. Sibley and has published in prestigious journals such as Cell, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Ace J. Hatch

19 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ace J. Hatch United States 13 238 186 100 75 74 21 468
Keiichiro Sakuma Japan 11 404 1.7× 126 0.7× 78 0.8× 89 1.2× 46 0.6× 19 567
Xuhong Fu China 12 488 2.1× 172 0.9× 87 0.9× 137 1.8× 64 0.9× 12 712
Jinwei Hao Australia 3 255 1.1× 197 1.1× 92 0.9× 129 1.7× 41 0.6× 3 432
Neha Luthar United States 6 236 1.0× 292 1.6× 139 1.4× 64 0.9× 37 0.5× 6 525
Frank He United States 7 278 1.2× 175 0.9× 102 1.0× 75 1.0× 57 0.8× 7 483
Lotte Hiddingh United States 8 214 0.9× 203 1.1× 88 0.9× 109 1.5× 22 0.3× 9 523
Zhenhai Lin China 9 329 1.4× 143 0.8× 96 1.0× 150 2.0× 70 0.9× 15 536
Changqie Pan China 14 288 1.2× 159 0.9× 115 1.1× 163 2.2× 41 0.6× 21 535
Igor Bado United States 13 331 1.4× 388 2.1× 119 1.2× 184 2.5× 67 0.9× 16 690
Ilenia Segatto Italy 14 290 1.2× 251 1.3× 99 1.0× 198 2.6× 51 0.7× 23 536

Countries citing papers authored by Ace J. Hatch

Since Specialization
Citations

This map shows the geographic impact of Ace J. Hatch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ace J. Hatch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ace J. Hatch more than expected).

Fields of papers citing papers by Ace J. Hatch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ace J. Hatch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ace J. Hatch. The network helps show where Ace J. Hatch may publish in the future.

Co-authorship network of co-authors of Ace J. Hatch

This figure shows the co-authorship network connecting the top 25 collaborators of Ace J. Hatch. A scholar is included among the top collaborators of Ace J. Hatch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ace J. Hatch. Ace J. Hatch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Limkakeng, Alexander T., Ace J. Hatch, Andrew B. Nixon, et al.. (2022). A Precision Medicine Approach to Stress Testing Using Metabolomics and Microribonucleic Acids. Personalized Medicine. 19(4). 287–297.
2.
Lafata, Kyle J., Michael N. Corradetti, Junheng Gao, et al.. (2021). Radiogenomic Analysis of Locally Advanced Lung Cancer Based on CT Imaging and Intratreatment Changes in Cell-Free DNA. Radiology Imaging Cancer. 3(4). e200157–e200157. 35 indexed citations
3.
Strickler, John H., Christel Rushing, Hope E. Uronis, et al.. (2021). Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer. The Oncologist. 26(6). 465–e917. 18 indexed citations
4.
Liu, Yingmiao, Jing Lyu, Kirsten B. Burdett, et al.. (2020). Prognostic and Predictive Biomarkers in Patients with Metastatic Colorectal Cancer Receiving Regorafenib. Molecular Cancer Therapeutics. 19(10). 2146–2154. 15 indexed citations
5.
Corradetti, Michael N., Jordan A. Torok, Ace J. Hatch, et al.. (2019). Dynamic Changes in Circulating Tumor DNA During Chemoradiation for Locally Advanced Lung Cancer. Advances in Radiation Oncology. 4(4). 748–752. 12 indexed citations
6.
Bonnans, Caroline, Delphine Grün, Chih‐Yang Wang, et al.. (2019). RasGRP1 is a potential biomarker for stratifying anti-EGFR therapy response in colorectal cancer. JCI Insight. 4(15). 18 indexed citations
7.
Innocenti, Federico, Chen Jiang, Alexander B. Sibley, et al.. (2019). An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance). Pharmacogenetics and Genomics. 29(6). 123–131. 5 indexed citations
8.
Strickler, John H., Christel Rushing, Donna Niedzwiecki, et al.. (2019). A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer. BMC Cancer. 19(1). 1032–1032. 9 indexed citations
9.
Innocenti, Federico, Chen Jiang, Alexander B. Sibley, et al.. (2018). Genetic variation determines VEGF-A plasma levels in cancer patients. Scientific Reports. 8(1). 16332–16332. 13 indexed citations
10.
Vlahovic, Gordana, Kellen L. Meadows, Ace J. Hatch, et al.. (2018). A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer. The Oncologist. 23(7). 782–790. 18 indexed citations
11.
Hatch, Ace J., Audrey R. Odom John, & John D. York. (2017). Inositol phosphate multikinase dependent transcriptional control. Advances in Biological Regulation. 64. 9–19. 21 indexed citations
12.
Seligmann, Jenny F., Ace J. Hatch, Susan D. Richman, et al.. (2017). Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal Cancer. JAMA Oncology. 4(4). 564–564. 19 indexed citations
13.
Corradetti, Michael N., Ace J. Hatch, Jordan A. Torok, et al.. (2017). Dynamic Changes in Cell-Free DNA During Chemoradiation for Non–small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 99(2). S114–S115.
14.
Hatch, Ace J., Alexander B. Sibley, Mark D. Starr, et al.. (2016). Blood‐based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance). Cancer Medicine. 5(9). 2249–2260. 17 indexed citations
15.
Nixon, Andrew B., Alexander B. Sibley, Ace J. Hatch, et al.. (2016). Blood-based biomarkers in patients (pts) with metastatic colorectal cancer (mCRC) treated with FOLFOX or FOLFIRI plus bevacizumab (Bev), cetuximab (Cetux), or Bev plus Cetux: Results from CALGB 80405 (Alliance).. Journal of Clinical Oncology. 34(15_suppl). 3597–3597. 12 indexed citations
16.
Hatch, Ace J., Jeffrey Clarke, Andrew B. Nixon, & Herbert I. Hurwitz. (2015). Identifying Blood-Based Protein Biomarkers for Antiangiogenic Agents in the Clinic. The Cancer Journal. 21(4). 322–326. 8 indexed citations
17.
Seligmann, Jenny F., Faye Elliott, Bart Jacobs, et al.. (2015). HER3 as a biomarker of prognosis and panitumumab (Pan) benefit in RAS-wt advanced colorectal cancer (aCRC).. Journal of Clinical Oncology. 33(15_suppl). 3583–3583. 1 indexed citations
18.
Jiang, Chen, Ace J. Hatch, Ivo Shterev, et al.. (2014). Gene Expression Markers of Efficacy and Resistance to Cetuximab Treatment in Metastatic Colorectal Cancer: Results from CALGB 80203 (Alliance). Clinical Cancer Research. 21(5). 1078–1086. 66 indexed citations
19.
Hatch, Ace J. & John D. York. (2010). SnapShot: Inositol Phosphates. Cell. 143(6). 1030–1030.e1. 83 indexed citations
20.
Prakash, Sumit, Tomonao Inobe, Ace J. Hatch, & Andreas Matouschek. (2008). Substrate selection by the proteasome during degradation of protein complexes. Nature Chemical Biology. 5(1). 29–36. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keiichiro Sakuma Breakdown of academic impact, for papers by Xuhong Fu Breakdown of academic impact, for papers by Jinwei Hao Breakdown of academic impact, for papers by Neha Luthar Breakdown of academic impact, for papers by Frank He Breakdown of academic impact, for papers by Lotte Hiddingh Breakdown of academic impact, for papers by Zhenhai Lin Breakdown of academic impact, for papers by Changqie Pan Breakdown of academic impact, for papers by Igor Bado Breakdown of academic impact, for papers by Ilenia Segatto
Rankless by CCL
2026